Avaleht › Haavandiline koliit › Indiana
Haavandiline koliit kliinilised uuringud osariigis Indiana
10 uuringut haiguse Haavandiline koliit jaoks otsivad osalejaid osariigis Indiana.
Linnad osariigis Indiana
Ametlik uuringutekst (inglise keeles)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Health Partners /ID# 284145, New Albany
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT07697456A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- IU Health University Hospital, Indianapolis
VärbamineFaas 3
Vanused 12 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Riley Hospital for Children, Indianapolis
VärbamineFaas 3
Vanused 3 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT06663332A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0100, Indianapolis
VärbamineFaas 2/3
Vanused 2–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Indiana University Health University Hospital, Indianapolis
- Gastroenterology Health Partners, New Albany
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Gastroenterology Health Partners, New Albany
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 22. sept 2026 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Health Partners, New Albany
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 22. sept 2026 · NCT07415044A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Health Partners, PLLC - New Albany - Site Number: 8400100, New Albany
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 15. sept 2026 · NCT07185009An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Health Partners, PLLC - Site Number: 8400100, New Albany
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 20. aug 2026 · NCT07184996Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 003, Indianapolis
VärbamineFaas 4
Vanused 5–17 · Kõik sood · Uuendatud 16. sept 2025 · NCT04314375Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.